Tag: MET

Exploratory treatment options fail in ccRCC 

Presented By
Prof. Thomas Powles, University of London, UK
Trial
Phase 2, CALYPSO
Conference
ASCO 2022
Type
Peer-reviewed article

5 August 2022 14:18

Savolitinib is effective in patients with MET-mutated NSCLC

Presented By
Dr Shun Lu, Shanghai Chest Hospital, China
Trial
Phase 2
Conference
ELCC 2022
Type
Peer-reviewed article

25 May 2022 12:39

MET-amplified advanced NSCLC responds well to MET inhibitor capmatinib

Presented By
Prof. Jürgen Wolf, University Hospital Cologne, Germany
Trial
Phase 2, GEOMETRY
Conference
ASCO 2020
Type
Peer-reviewed article

8 September 2020 13:07
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com